CA9 and breast cancer: For instance, different classes of sulfonamides and their analogs were found to inhibit CA IX activity and breast cancer cell growth and migration in vitro, and some of them exhibited anticancer activity in xenograft subcutaneous and metastatic mouse models [14,15].